Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Richard Hunter

Tracked across 4 events · 39 articles · First seen May 12, 2026 · Last active Aug 17, 2026

Sentiment
0
Attention
6
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 0
Business
Impact: As head of markets at Interactive Investor, Richard Hunter commented on WHSmith's capital raise, suggesting it could be a critical move for the company and would test investor patience.
Jun 10, 2026 · 7 articles
4 0
Business
Impact: Richard Hunter, head of markets at Interactive Investor, commented on Vodafone Idea's stock performance and investor sentiment.
May 12, 2026 · 6 articles
4 0
Business
AstraZeneca announced on August 17, 2026, that it is discontinuing the Phase III EVOLVE-Lung02 trial of volrustomig plus chemotherapy in patients with metastatic non-small cell lung cancer (mNSCLC). The decision followed a recommendation from an…
Impact: Richard Hunter, head of markets at interactive investor, commented on AstraZeneca's shares being higher despite the setback, highlighting the strength of its oncology pipeline.
Aug 17, 2026 · 20 articles
6 0
Business
Impact: Richard Hunter, head analyst at Interactive Investor, commented on Marks & Spencer's performance and investments despite the cyber attack.
May 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Richard Hunter live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.